Australia markets closed

Core Laboratories Inc. (CLB)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
16.94-0.13 (-0.76%)
At close: 04:02PM EDT
16.94 0.00 (0.00%)
After hours: 05:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close17.07
Open17.16
Bid16.41 x 1800
Ask17.47 x 900
Day's range16.79 - 17.54
52-week range13.82 - 27.95
Volume522,902
Avg. volume435,450
Market cap790.495M
Beta (5Y monthly)2.43
PE ratio (TTM)33.22
EPS (TTM)0.51
Earnings date30 Jan 2024 - 05 Feb 2024
Forward dividend & yield0.04 (0.23%)
Ex-dividend date03 May 2024
1y target est19.50
  • Thomson Reuters StreetEvents

    Q1 2024 Core Laboratories Inc Earnings Call

    Q1 2024 Core Laboratories Inc Earnings Call

  • Zacks

    Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates

    Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.

  • PR Newswire

    CORE LAB REPORTS FIRST QUARTER 2024 RESULTS

    Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,900,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. During the first quarter of 2024, the Company recorded: 1) appr